RhythmScience Announces Formation of Medical Advisory Board
/PRNewswire/ -- RhythmScience, a leader in cardiac data management and services, today announced the formation of its Medical Advisory Board (MAB). Comprised...
Stay updated with breaking news from Arvind Bhimaraj. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- RhythmScience, a leader in cardiac data management and services, today announced the formation of its Medical Advisory Board (MAB). Comprised...
Vuzix Corporation (NASDAQ:VUZI) has announced the introduction of the Zoom for smart glasses application by Vuzix on the Zoom App Marketplace. The company,...
Vuzix Corporation (NASDAQ:VUZI) has announced the introduction of the Zoom for smart glasses application by Vuzix on the Zoom App Marketplace. The company,...
Cardiol Therapeutics Inc.: Cardiol Therapeutics Announces Filing of 2020 Year-End Financial Statements and MD&A Cardiol Therapeutics Inc. ( a clinical-stage biotechnology company focused on developing innovative anti-inflammatory therapies for the treatment of cardiovascular disease, today filed its audited Financial Statements and Management's Discussion and Analysis for the year ended December 31, 2020. Both are available under the Company's profile on SEDAR at www.sedar.com and on the Company's website at www.cardiolrx.com. David Elsley, President and Chief Executive Officer of Cardiol, co...